JCR Pharmaceuticals’ unique brain-shuttling technology opens new treatment opportunities for meeting the needs of patients grappling with CNS diseases. Getting drugs from the bloodstream into the ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...

HIGHS Absolutely silent inside, highest level of fit and finish, makes the same high-end statement as gas-powered Rolls-Royces. LOWS Less driving range than other high-dollar EVs, road manners a bit ...

In the United States alone, the annual socioeconomic costs of disorders such as stroke, depression, schizophrenia and Alzheimer's disease (AD) are currently estimated at over US$250 billion 1,2, and ...